Nuvothera

Psoriasis is a chronic inflammatory skin condition that's unsightly, embarrassing,and difficult to treat. Patients are concerned about the inconsistent efficacy and dangerous side effects of prescription drugs. Current OTC products lack innovation and consumer appeal because they're outdated, greasy, and smelly and they are required to be applied many times a day. Our products are innovative and highly effective. They are next generation products that produce prescription-like results, are safer than Rx drugs and are modern formuations that posess pleasant cosmetic attrbutes and high customer appeal. Nuvothera will soon launch additional advanced and innovative OTC products for the treatment of eczema, acne, rosacea, warts and nail fungus.

Doubled sales yearly on internet sales Achieved huge milestone of expanding distribution into Walgreens, CVS, and soon Walmart In first 2 months, became the top selling brand in category at Walgreens, growing 27% MoM With the significant growth in distribution, sales growth will exceed 5X in 2025

• 
  Follow the Money: Nuvothera Raises $2.06M, Naya Ventures Nets $2M, Investar Seeks $5M

  Dallas Innovates · Mar 1, 2018

  From a maker of a psoriasis treatment to a warm-cookie delivery company, here are some of the latest capital raises, mergers, and acquisitions with North Texas ties.

• 
  Fort Worth Entrepreneur Bringing Psoriasis Cream to Market

  Dallas Innovates · Apr 12, 2017

  Art Clapp is continuing his pharmaceutical endeavors with a new product from his company, NuvoThera.